Nuventra Pharma Sciences Appoints Mark A. Bush, Ph.D. As Chief Scientific Officer

Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, today announced that Mark A. Bush, Ph.D. has been appointed to the role of Chief Scientific Officer (CSO). Dr. Bush had served as the Senior Director, Clinical Pharmacokinetics (PK) at Nuventra prior to assuming duties as CSO. Dr. Bill Wargin, who had been CSO since the company’s inception, remains with the company in an emeritus position as Executive Vice President of Pharmacokinetics.

Help employers find you! Check out all the jobs and post your resume.